Examples of using Is in place and functioning in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
As described in version 3.0 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and a.
The MAH must ensure that the system of pharmacovigilance is in place and functioning before the product is placed on the market.
the system of pharmacovigilance, as described in version 2 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market.
The Marketing Authorisation Holder must ensure that the system of pharmacovigilance is in place and functioning prior to placing the product on the market.
The MAH must ensure that the system of pharmacovigilance, as described in version version 1.1 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market.
as presented in Module 1.8.1. of the Marketing Authorisation, is in place and functioning before and whilst the medicinal product is on the market.
the system of pharmacovigilance, as described in version 4.0 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market.
The MAH must ensure that the system of pharmacovigilance, presented in Module 1.8.1. of the Marketing Authorisation, is in place and functioning before and whilst the product is on the market.
Pharmacovigilance system The MAH must ensure that the system of pharmacovigilance, as described in version 2.0 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market.
presented in Module 1.8.1 of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market.
as described in Part 1 of the marketing authorisation application, is in place and functioning before and whilst the product is on the market.
presented in Module 1.8.1. of the Marketing Authorisation, is in place and functioning before and whilst the product is placed on the market.
The MAH must ensure that the system of pharmacovigilance, as described in version 2.0 presented in Module 1.8.1. of the Marketing Authorisation, is in place and functioning before and whilst the product is on the market.
The MAH must ensure that the system of pharmacovigilance, as described in version 2.0 dated 25 September 2007 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market.
the system of pharmacovigilance, as described in version 2.0 presented in Module of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market.
the system of pharmacovigilance, as described in version 4.0 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market.
as described in version 20 October 2009 presented in Module 1.8.1. of the Marketing Authorisation, is in place and functioning before and whilst the product is on the market.
as described in version 2.0 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market.
the system of pharmacovigilance, as described in version v.003/ 20071203 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market.
ensure that the system of pharmacovigilance, as described in version 3 dated September 2007 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market.
Pharmacovigilance system The MAH must ensure that the system of pharmacovigilance, as described in version 1.0 presented in Module 1.8.1. of the Marketing Authorisation, is in place and functioning before and whilst the product is on the market.
any subsequent updates, is in place and functioning before and whilst the product is on the market.
the system of pharmacovigilance, as described in the version dated 10 May 2007 presented in Module 1.8.1. of the Marketing Authorisation Application, is in place and functioning before and whilst the product is on the market.
to establish the modalities by which Member States give the assurance that the systems are in place and function satisfactorily.